OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-28 Cr | ₹2.83 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.68 Cr |
What is the latest Cash Flow from Operating Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-28 Cr |
| Mar2025 | ₹2.83 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-1.63 Cr |
| Mar2022 | ₹-1.68 Cr |
How is Cash Flow from Operating Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-28 Cr | Negative | |
| Mar2025 | ₹2.83 Cr | Positive | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-1.63 Cr | Negative | |
| Mar2022 | ₹-1.68 Cr | - | |
Compare Cash Flow from Operating Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.0 Cr | 2.1% | 6.4% | -20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 2.1% |
6.4% |
-20.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses